Advancing brain cancer research, one discovery at a time.
Since our inception in 2001, we have persistently invested in
innovative and ground-breaking research.
Our Research Impact
We are making steady but vital progress in brain cancer research. Our impact extends far beyond the lab and has helped to establish partnerships and global collaborations right across the brain cancer ecosystem.
91 Research Investments
have been awarded to innovative projects across the country.
120,593 Drug Compounds
3,064 Brain Cancer Resources
1160 National and International Partnerships
125 Institutions and Hospital Sites
83 Researchers’ Salaries
Investing in Talent
Our Fellowship program attract, retain, and support the most promising emerging researchers—those with the intellect, curiosity, and commitment needed to tackle one of the most complex and underfunded cancers.
Over $3 million in funding has been awarded to 8 early and mid-career researchers to support novel, impactful science, and back brilliant scientists at key points in their careers. Nurturing talent at this critical stage is not just an investment in individuals, but in the future of brain cancer research itself. We are making steady but vital progress in brain cancer research. Our impact extends far beyond the lab and has helped to establish partnerships and global collaborations right across the brain cancer ecosystem.
Chris O’Brien Lifehouse
Investigating extracellular vesicle molecular signatures to enhance understanding of brain cancer biology and improve diagnostic and therapeutic strategies
Monash University
Exploring the potential of PMR-116, a novel RNA Polymerase 1 inhibitor, as a treatment for brain cancers with H3.3 and ATRX mutations.
Monash University
Targeting damaged PML bodies in paediatric gliomas using engineered models and patient samples to assess the efficacy of clinically approved drugs.
WEHI
Developing innovative immunotherapies for paediatric brain cancer to advance treatment options for young patients.
Supporting Research Around Australia
We fund the most promising brain cancer research across the country. We go where the innovation is, not where it's easiest, because bold ideas can come from anywhere.
Overseas
Our commitment to funding groundbreaking research extends beyond Australia.
To date, we’ve invested $9.88 million in collaborations with the USA that have helped bring international clinical trials to Australian patients and enabled funding for Australian researchers working on paediatric brain cancer.
Impactful Collaborations
We believe that collaboration is key to finding a cure. That’s why we’ve built powerful partnerships throughout the brain cancer ecosystem: to enhance the mission of all organisations, build on our combined resources and provide the best care possible for patients living with brain cancer.
Clinical Trials
We are passionate about making cutting-edge treatments available to Australians through clinical trials. We have invested over $11 million in clinical trials, including $8 million into the revolutionary GBM AGILE.
Key Partnerships
Peace of Mind Foundation
The National Advocacy Service (NAS) is delivered by Peace of Mind Foundation, underpinned by a mission-oriented funding
collaboration from Cure Brain Cancer Foundation and support from our generous donor community.
The NAS team goes to great lengths to help families living with brain cancer access vital support services, resources and advice that can make their lives easier following a devastating diagnosis. We know that navigating essential services like the National Disability Insurance Scheme (NDIS) funding can be especially challenging for patients and their families. That’s why dedicated NAS advocates help families access critical community and government services, ensuring they get the support they need when they need it most.
Australian Brain Tumour Collaborative
We are a proud founding partner of the Australian Brain Tumour Collaborative. The Collaborative aims to develop and convey a united national voice that provides consolidated and evidence-based advocacy to governments, stakeholders and the Australian brain cancer patient, family and carer community.
This advocacy seeks to clearly define key issues and national responses that achieve better support and outcomes for individuals, carers and families impacted by brain tumour in Australia. In particular, responses and actions to minimise the significant challenges the disease and treatments present to consumers from date of diagnosis and through the survivorship journey.
DIPG/DMG Collaborative
The DIPG/DMG Collaborative is a collection of foundations with the common interest of inspiring research into the cure of Diffuse Intrinsic Pontine Glioma (DIPG) and Diffuse Midline Glioma (DMG) with the belief that through a cure for DIPG/DMG, significant advances in other cancer research will be made.
The DIPG/DMG Collaborative funds both clinical and translational research worldwide.
Cure Brain Cancer Foundation has proudly contributed to the Collaborative since 2015. We are committed to persistently investing in paediatric brain cancer research and believe it is the most promising path towards improving the grim statistics that are inextricably linked to this disease.
Brain Tumour Alliance Australia
Working alongside Brain Tumour Alliance Australia, we support a coordinated national approach to patient advocacy and support.
This partnership strengthens the collective voice of the sector and helps ensure that the needs of patients and families are consistently represented across policy, service delivery and community engagement.